280 related articles for article (PubMed ID: 24839594)
1. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.
Tomatsu S; Mackenzie WG; Theroux MC; Mason RW; Thacker MM; Shaffer TH; Montaño AM; Rowan D; Sly W; Alméciga-Díaz CJ; Barrera LA; Chinen Y; Yasuda E; Ruhnke K; Suzuki Y; Orii T
Res Rep Endocr Disord; 2012 Dec; 2012(2):65-77. PubMed ID: 24839594
[TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
[TBL] [Abstract][Full Text] [Related]
3. Therapies for the bone in mucopolysaccharidoses.
Tomatsu S; Alméciga-Díaz CJ; Montaño AM; Yabe H; Tanaka A; Dung VC; Giugliani R; Kubaski F; Mason RW; Yasuda E; Sawamoto K; Mackenzie W; Suzuki Y; Orii KE; Barrera LA; Sly WS; Orii T
Mol Genet Metab; 2015 Feb; 114(2):94-109. PubMed ID: 25537451
[TBL] [Abstract][Full Text] [Related]
4. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
[TBL] [Abstract][Full Text] [Related]
6. Mucopolysaccharidosis IVA and glycosaminoglycans.
Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
[TBL] [Abstract][Full Text] [Related]
8. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
[TBL] [Abstract][Full Text] [Related]
9. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
[TBL] [Abstract][Full Text] [Related]
10. Natural history of Morquio A patient with tracheal obstruction from birth to death.
Doherty C; Averill LW; Theroux M; Mackenzie WG; Pizarro C; Mason RW; Tomatsu S
Mol Genet Metab Rep; 2018 Mar; 14():59-67. PubMed ID: 29326877
[TBL] [Abstract][Full Text] [Related]
11. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
[TBL] [Abstract][Full Text] [Related]
12. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
[TBL] [Abstract][Full Text] [Related]
13. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.
Leong HY; Abdul Azize NA; Chew HB; Keng WT; Thong MK; Mohd Khalid MKN; Hung LC; Mohamed Zainudin N; Ramlee A; Md Haniffa MA; Yakob Y; Ngu LH
Orphanet J Rare Dis; 2019 Jun; 14(1):143. PubMed ID: 31200731
[TBL] [Abstract][Full Text] [Related]
15. Current therapies for Morquio A syndrome and their clinical outcomes.
Sawamoto K; Suzuki Y; Mackenzie WG; Theroux MC; Pizarro C; Yabe H; Orii KE; Mason RW; Orii T; Tomatsu S
Expert Opin Orphan Drugs; 2016; 4(9):941-951. PubMed ID: 28217429
[TBL] [Abstract][Full Text] [Related]
16. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Tomatsu S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.
Akyol MU; Alden TD; Amartino H; Ashworth J; Belani K; Berger KI; Borgo A; Braunlin E; Eto Y; Gold JI; Jester A; Jones SA; Karsli C; Mackenzie W; Marinho DR; McFadyen A; McGill J; Mitchell JJ; Muenzer J; Okuyama T; Orchard PJ; Stevens B; Thomas S; Walker R; Wynn R; Giugliani R; Harmatz P; Hendriksz C; Scarpa M; ;
Orphanet J Rare Dis; 2019 Jun; 14(1):137. PubMed ID: 31196221
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]